Systemic immune-inflammation index is a stage-dependent prognostic factor in patients with operable non-small cell lung cancer

BACKGROUND: Immune function is a key component affecting tumor progression in patients with cancer. The purpose of this study was to identify the prognostic value of systemic immune-inflammation index (SII) in patients with non-small cell lung cancer (NSCLC) and the differences of its prognostic val...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Fangqiu, Deng, Chaoqiang, Wen, Zhexu, Gao, Zhendong, Zhao, Yue, Han, Han, Zheng, Shanbo, Wang, Shengping, Li, Yuan, Hu, Hong, Zhang, Yang, Chen, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350100/
https://www.ncbi.nlm.nih.gov/pubmed/34430354
http://dx.doi.org/10.21037/tlcr-21-267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350100/
https://www.ncbi.nlm.nih.gov/pubmed/34430354
http://dx.doi.org/10.21037/tlcr-21-267

Ejemplares similares